info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

AI Drug Discovery Companies

AI in drug discovery has become a transformative force, revolutionizing the pharmaceutical industry by accelerating the drug development process, reducing costs, and improving the efficiency of drug discovery pipelines. Numerous companies are leveraging artificial intelligence (AI) and machine learning (ML) technologies to streamline various aspects of drug discovery, from target identification and lead optimization to clinical trial design and personalized medicine

Top Industry Leaders in the AI Drug Discovery Market

Artificial Intelligence in Drug Discovery Key Companies

 


Latest Artificial Intelligence in Drug Discovery Companies Update:

Exscientia expands collaboration with Merck KGaA: This multi-year partnership leverages Exscientia's AI-powered drug design platform to discover small molecule drug candidates across several therapeutic areas like oncology, neuroinflammation, and immunology.


BenevolentAI partners with AstraZeneca: This collaboration utilizes BenevolentAI's AI platform to analyze vast datasets and identify promising drug targets for neurodegenerative diseases, aiming to accelerate preclinical research.


Intellia Therapeutics collaborates with Verily Life Sciences: This partnership combines Intellia's CRISPR gene editing technology with Verily's AI and data analytics expertise to optimize gene editing therapies for targeted diseases.


List of Artificial Intelligence in Drug Discovery Key companies in the market

  • IBM (US)

  • Alphabet Inc (US)

  • Atomwise Inc (US)

  • Deep Genomics (Canada)

  • Cloud Pharmaceuticals, Inc (US)

  • Microsoft corporation (US)

  • Insilico Medicine (China)

  • Cyclica (Canada)

  • BenevolentAI (UK)

  • Exscientia (UK)


Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.